Core Viewpoint - The article highlights PennantPark Floating Rate Capital as a potentially safe investment opportunity with a double-digit yield of 13.6%, making it an attractive option for income-seeking investors [11][21]. Company Overview - PennantPark Floating Rate Capital is a small-cap business development company (BDC) that invests in the equity and debt of middle-market companies, with a focus on generating high yields [11][12]. - As of September 30, 2025, the company had an investment portfolio valued at approximately $2.77 billion, with 91% of it tied up in loans [13]. Financial Performance - The weighted-average yield on PennantPark's debt investments was reported at 10.2%, significantly higher than the yield from 30-year Treasury bonds [13]. - The company has a diverse portfolio consisting of 164 holdings, with an average investment size of $16.9 million, which helps mitigate risk [17]. - 99.2% of its loan portfolio is first-lien secured debt, providing a layer of protection in case of borrower defaults [18]. Dividend Information - PennantPark offers a monthly dividend of $0.1025 per share, translating to an annual yield of 13.6% [21]. - The company's share price closed at $9.07, representing a 16% discount to its GAAP net asset value (NAV) per share of $10.83 [20]. Market Context - The article emphasizes the historical outperformance of dividend stocks compared to non-payers, with dividend stocks yielding an average annual return of 9.2% over the past 51 years, while non-payers yielded only 4.31% [6].

Houston, Texas-based Kinder Morgan, Inc. (KMI) operates as an energy infrastructure company. Valued at $60.5 billion by market cap, the company owns and operates pipelines that transport natural gas, gasoline, crude oil, carbon dioxide, and other products, as well as terminals that store petroleum products and chemicals and handle bulk materials like coal and petroleum coke. The midstream giant is expected to announce its fiscal fourth-quarter earnings for 2025 in the near future. Ahead of the event, ana ...

Portage, Michigan-based Stryker Corporation (SYK) is a leading global medical technology company specializing in orthopaedics, MedSurg, and neurotechnology solutions, serving hospitals and healthcare providers worldwide. Valued at $135.7 billion by market cap, the company is best known for its joint-replacement implants, surgical equipment, and advanced technologies, including the Mako robotic-assisted surgery platform, which enhances procedural precision and efficiency. The Medtech giant is expected to ...

Valued at $35.6 billion by market cap, Sysco Corporation (SYY) is a leading American multinational food-service distribution company and a core participant in the consumer staples sector. Headquartered in Houston, Texas, Sysco primarily markets and distributes a broad range of food and related products, including fresh, frozen, and prepared foods, meat, seafood, produce, dairy, beverages, and imported specialties, as well as non-food items such as disposable paper products, tableware, kitchen equipment, an ...

Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Gemini is executing a silent takeover of the generative AI market, surging to an 18.2% traffic share in just one year while industry pioneer ChatGPT suffers a massive double-digit decline in dominance.The Great AI MigrationNew data from Similarweb reveals a dramatic reshaping of the AI landscape. Over the last 12 months, Google's Gemini has more than tripled its slice of generative AI web traffic, climbing from a modest 5.4% to 18.2%.This surge comes directly at ...

Seattle, Washington-based Starbucks Corporation (SBUX) is the world’s largest specialty coffee roaster and retailer. With a global footprint of tens of thousands of stores across more than 87 countries, it currently holds a market cap of $96.2 billion. Founded in 1971, Starbucks operates primarily through company-operated and licensed retail stores offering premium coffee, espresso beverages, teas, food items, packaged goods, and merchandise under brands such as Starbucks Coffee, Teavana, Seattle’s Best Co ...

Steel Dynamics, Inc. (STLD), headquartered in Fort Wayne, Indiana, functions as a leading steel producer and metal recycler. Valued at $25.6 billion by market cap, the company’s products include flat rolled steel sheet, engineered bar, special-bar-quality, and structural beams. It also recycles scrap metal and manufactures non-residential building components, including steel joists, girders, trusses, and decks, for construction projects. The leading domestic steel producer and metals recycler is expected t ...

Social Security tax rules will change in 2026.Getty Images; Tyler Le/BI Social Security tax rules will change in 2026 at the state and federal level. West Virginia will stop taxing Social Security benefits, leaving seven states that tax benefits. Older Americans will also see expanded federal tax breaks through 2028. Americans on Social Security could see new federal tax breaks in 2026 — and some states will stop taxing benefit income. The largest social safety net in the US provides monthly paym ...

SEOUL, South Korea, Dec. 26, 2025 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement for its Grabody platform, and a USD 15 million equity investment from Eli Lilly and Company (”Lilly”).ABL Bio and Lilly are currently conducting joint research and development on multiple therapeutic candidates leveraging the Grabody platform across various mod ...

Industry Overview - The drug and biotech sector experienced a volatile performance in 2025, with a significant recovery in the last few months attributed to improved drug pricing policies and strong merger and acquisition activity [2] - The biotech sector has rallied 26% over the past six months, outperforming the S&P 500 index [2] Innovation and Regulatory Activity - Key growth areas in the industry include obesity, gene therapy, inflammation, and neuroscience, attracting investor interest [3] - The FDA approved 44 novel therapies as of December 22, 2025, indicating healthy regulatory activity [3] Company Highlights Mineralys Therapeutics - Mineralys is developing lorundrostat, an aldosterone synthase inhibitor for uncontrolled hypertension, chronic kidney disease, and obstructive sleep apnea [5] - The pivotal phase III Launch-HTN study and phase II Advance-HTN study met primary efficacy endpoints, showing favorable safety [6] - The company plans to submit a new drug application for lorundrostat in early 2026, with shares up 203.4% year-to-date [8][9] Lyell Immunopharma - Lyell focuses on next-generation CAR T-cell therapies, with its lead candidate ronde-cel for large B-cell lymphoma [11] - A pivotal phase III study for ronde-cel is expected to begin in early 2026, and the company has a strong cash position of approximately $320 million [14] - Shares have increased by 191.6% in 2025, with loss per share estimates narrowing from $12.68 to $9.70 [15] Insmed - Insmed markets Arikayce for refractory MAC lung disease, generating $314.5 million in sales in the first nine months of 2025, a 21% increase year-over-year [16] - The FDA approved Brinsupri for non-CF bronchiectasis, with sales of $28.1 million in Q3 2025 [17] - Despite a setback with the BiRCh study, the company is evaluating Brinsupri for hidradenitis suppurativa, with shares up 156% year-to-date [19][20] Nektar Therapeutics - Nektar is developing rezpegaldesleukin for atopic dermatitis and alopecia areata, with positive data from phase IIb studies [21][22] - The company plans to advance rezpeg into phase III development in 2026, with shares soaring 218.8% year-to-date [24][25]